These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31071422)

  • 41. Subchronic and Low Dose of Tributyltin Exposure Leads to Reduced Ovarian Reserve, Reduced Uterine Gland Number, and Other Reproductive Irregularities in Female Mice.
    Sarmento IV; Merlo E; Meyrelles SS; Vasquez EC; Warner GR; Gonsioroski A; De La Torre K; Meling DD; Flaws JA; Graceli JB
    Toxicol Sci; 2020 Jul; 176(1):74-85. PubMed ID: 32239163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resumption of ovarian function during lactational amenorrhoea in breastfeeding women with polycystic ovarian syndrome: metabolic aspects.
    Maliqueo M; Sir-Petermann T; Salazar G; Pérez-Bravo F; Recabarren SE; Wildt L
    Hum Reprod; 2001 Aug; 16(8):1598-602. PubMed ID: 11473949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats.
    Jahan S; Munir F; Razak S; Mehboob A; Ain QU; Ullah H; Afsar T; Shaheen G; Almajwal A
    J Ovarian Res; 2016 Dec; 9(1):86. PubMed ID: 27923406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of oxidative stress and low-grade inflammation in letrozole-induced polycystic ovary syndrome in the rat.
    Pandey V; Singh A; Singh A; Krishna A; Pandey U; Tripathi YB
    Reprod Biol; 2016 Mar; 16(1):70-7. PubMed ID: 26952756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
    Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular and molecular mechanisms of pentoxifylline's beneficial effects in experimental polycystic ovary.
    Rezvanfar MA; Saadat S; Shojaei Saadi HA; Mansoori P; Saeedi S; Gooshe M; Baeeri M; Abdollahi M
    Theriogenology; 2015 Apr; 83(6):968-77. PubMed ID: 25557188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Syzygium cumini (L.) Skeels improves metabolic and ovarian parameters in female obese rats with malfunctioning hypothalamus-pituitary-gonadal axis.
    Benevides ROA; Vale CC; Fontelles JLL; França LM; Teófilo TS; Silva SN; Paes AMA; Gaspar RS
    J Ovarian Res; 2019 Feb; 12(1):13. PubMed ID: 30717749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Controlling effect of bushen huatan compound on the insulin signal conducting molecule inside ovaries in polycystic ovary syndrome model rats].
    Liang C; Cong J; Chang H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1639-44. PubMed ID: 22384551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.
    Hahn S; Backhaus M; Broecker-Preuss M; Tan S; Dietz T; Kimmig R; Schmidt M; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Aug; 157(2):201-7. PubMed ID: 17656599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormone-induced rat model of polycystic ovary syndrome: A systematic review.
    Noroozzadeh M; Behboudi-Gandevani S; Zadeh-Vakili A; Ramezani Tehrani F
    Life Sci; 2017 Dec; 191():259-272. PubMed ID: 29055801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
    Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
    Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced Inflammation without Impairment of Insulin Signaling in the Visceral Adipose Tissue of 5α-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome.
    Milutinović DV; Nikolić M; Veličković N; Djordjevic A; Bursać B; Nestorov J; Teofilović A; Antić IB; Macut JB; Zidane AS; Matić G; Macut D
    Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):522-529. PubMed ID: 28407665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat.
    Dissen GA; Lara HE; Leyton V; Paredes A; Hill DF; Costa ME; Martinez-Serrano A; Ojeda SR
    Endocrinology; 2000 Mar; 141(3):1073-82. PubMed ID: 10698183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
    Rajan RK; M SS; Balaji B
    Pharm Biol; 2017 Dec; 55(1):242-251. PubMed ID: 27927075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function.
    Radavelli-Bagatini S; Blair AR; Proietto J; Spritzer PM; Andrikopoulos S
    J Endocrinol; 2011 Jun; 209(3):307-15. PubMed ID: 21429962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.
    Lai H; Jia X; Yu Q; Zhang C; Qiao J; Guan Y; Kang J
    Biol Reprod; 2014 Nov; 91(5):127. PubMed ID: 25100714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polycystic ovary syndrome and the metabolic syndrome.
    Weerakiet S
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
    Legro RS; Finegood D; Dunaif A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Environmental obesogen tributyltin chloride leads to abnormal hypothalamic-pituitary-gonadal axis function by disruption in kisspeptin/leptin signaling in female rats.
    Sena GC; Freitas-Lima LC; Merlo E; Podratz PL; de Araújo JF; Brandão PA; Carneiro MT; Zicker MC; Ferreira AV; Takiya CM; de Lemos Barbosa CM; Morales MM; Santos-Silva AP; Miranda-Alves L; Silva IV; Graceli JB
    Toxicol Appl Pharmacol; 2017 Mar; 319():22-38. PubMed ID: 28161095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Dietary Medium-Chain Fatty Acid, Decanoic Acid, Inhibits Recruitment of Nur77 to the HSD3B2 Promoter In Vitro and Reverses Endocrine and Metabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
    Lee BH; Indran IR; Tan HM; Li Y; Zhang Z; Li J; Yong EL
    Endocrinology; 2016 Jan; 157(1):382-94. PubMed ID: 26465200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.